Results 191 to 200 of about 27,437,097 (250)

Treatment option for chronic hepatitis B.

JPMA. The Journal of the Pakistan Medical Association, 2001
openaire   +1 more source

Some of the next articles are maybe not open access.

Related searches:

In-Person Health Care as Option B

New England Journal of Medicine, 2018
In-Person Health Care as Option B Face-to-face interactions will certainly always have a central role in health care.
Sean, Duffy, Thomas H, Lee
openaire   +3 more sources

Long-term virological outcomes in women who started option B+ care during pregnancy for prevention of mother-to-child transmission of HIV in Dar es Salaam, Tanzania: a cohort study.

The Lancet HIV, 2021
BACKGROUND Option B+ marked a milestone in prevention of mother-to-child transmission (PMTCT) of HIV by recommending lifelong antiretroviral therapy (ART) for all pregnant women with HIV.
G. Lyatuu, Shally Mwashemele, R. Urrio, H. Naburi, Nassir Kashmir, Lameck Machumi, A. Kibao, Ziada Sellah, Nzovu K. Ulenga, N. Orsini, G. Biberfeld, C. Kilewo, A. Ekström   +12 more
semanticscholar   +1 more source

Pharmacotherapeutic options for hepatitis B

Expert Opinion on Pharmacotherapy, 2015
Hepatitis B virus (HBV) is the driving force of disease progression in chronic hepatitis B. Patients with active HBV replication and/or significant liver disease require timely treatment. Currently, pegylated interferon-α (PEG IFN), entecavir (ETV) and tenofovir disoproxil fumarate (TDF) are the preferred first-line drugs.A finite course IFN-based ...
Yi-Cheng, Chen, Yun-Fan, Liaw
openaire   +2 more sources

Pharmacotherapy options for managing hepatitis B in children

Expert Opinion on Pharmacotherapy, 2021
To eliminate viral hepatitis by 2030, the World Health Organization (WHO) launched the first global health sector strategy on viral hepatitis, with particular focus given to hepatitis B and C in 2016. To achieve the reduction of mortality in children, it is indispensable to know which children should be treated and how to treat them.In this article ...
Haruki Komatsu, Ayano Inui, Sachiyo Yoshio, Tomoo Fujisawa   +3 more
openaire   +2 more sources

New options to treat influenza B

Nature Microbiology, 2017
Influenza B virus causes substantial illness globally, particularly in children. Treatment options are limited, as the most widely used antiviral drug appears to be less effective than against influenza A. A new antibody targeting the influenza B neuraminidase shows promise in mice as a therapeutic option.
Aeron C, Hurt, Kanta, Subbarao
openaire   +2 more sources

Options and Strategies for Transition to GDA94

Australian Surveyor, 1997
The adoption of a new geocentric datum in Australia has been recently proposed. In accepting this proposal. options for making the transition to the new datum will need to be carefully considered. Spatial data can take various forms. ranging from survey control networks through to plans. maps and digital geographic information systems. All such spatial
P. A. Collier, F. J. Leahy, V. S. Argeseanu   +2 more
openaire   +1 more source

PMTCT care cascade and factors associated with attrition in the first four years after Option B+ implementation in Mozambique

Tropical medicine & international health, 2020
To evaluate the effectiveness of the prevention of mother‐to‐child transmission (PMTCT) Option B+ programme in two provinces with high human immunodeficiency virus (HIV) burden in Mozambique over the first four years of programme implementation.
Laurence Ahoua, T. Tiendrebeogo, Shino Arikawa, M. Lahuerta, Dario Aly, V. Journot, E. Abrams, R. Becquet, F. Dabis   +8 more
semanticscholar   +1 more source

Growth and neurodevelopment outcomes in HIV, tenofovir and efavirenz exposed breastfed infants in PMTCT Option B+ program in Malawi.

Journal of Acquired Immune Deficiency Syndromes, 2020
BACKGROUND Pregnant and breastfeeding women in Option B+ in Malawi received antiretroviral drugs (ARVs) containing efavirenz (EFV) and tenofovir disoproxil fumarate (TDF).
A. Kapito-Tembo, A. Bauleni, A. Wesevich, Dennis Ongubo, M. Hosseinipour, Q. Dube, P. Mwale, A. Corbett, V. Mwapasa, S. Phiri   +9 more
semanticscholar   +1 more source

Medicare Part B: Physician Participation Options

The Journal of Bone and Joint Surgery-American Volume, 2008
Orthopaedic surgeons in the United States have recently been facing the challenge of caring for their patients in the face of rising costs and declining reimbursements. While medical practice expenses and professional liability insurance rates have been increasing, the average Medicare reimbursement rates for the twenty-five most frequently performed ...
Sanaz, Hariri, Kevin J, Bozic, Mary I, O'Connor, Harry E, Rubash   +3 more
openaire   +2 more sources